반응식
[N:1]1[C:5]2[CH2:6][CH2:7][CH:8]([C:10]([OH:12])=O)[CH2:9][C:4]=2[NH:3][CH:2]=1.[Cl:13][C:14]1[CH:24]=[CH:23][C:17]([O:18][CH2:19][CH2:20][CH2:21][NH2:22])=[CH:16][CH:15]=1>>[ClH:13].[Cl:13][C:14]1[CH:24]=[CH:23][C:17]([O:18][CH2:19][CH2:20][CH2:21][NH:22][C:10]([CH:8]2[CH2:7][CH2:6][C:5]3[NH:1][CH:2]=[N:3][C:4]=3[CH2:9]2)=[O:12])=[CH:16][CH:15]=1참가 물질
3
실험 절차
By a similar procedure as described in Example 65, the title compound was prepared from 4,5,6,7-tetrahydrobenzimidazole-5-carboxylic acid and 3-(4-chlorophenoxy)propylamine.
출처 및 근거
- ORD 기록
- ord-60d1c6532cd044f2beb418894ce8c83b
- 출처 데이터셋
- uspto-grants-2002_08
- 특허 번호
- US06437147B1
연결된 노트
불러오는 중…